InsCorp, Inc. Reports Results for 4Q25 and 2025

Core Insights - InsCorp, Inc. (OTCQX: IBTN) has crossed the $1 billion asset mark and approved a quarterly dividend increase while adding a healthcare veteran to its board [1][15]. Financial Performance - The company reported earnings per share (EPS) of $1.52 for 2025, down from $2.55 in 2024, with a fourth-quarter EPS of ($0.57) compared to $0.67 in 4Q24. The EPS was impacted by a pretax loss of $4,948,584 due to fraud, which was fully charged off in 4Q25 [1]. - Return on assets (ROA) was 0.46% in 2025, down from 0.87% in 2024, while return on average tangible common equity (ROATCE) decreased to 5.8% from 10.3% in the previous year [1]. - Revenue grew by 16% year-over-year (Y/Y), but overhead increased by 25% Y/Y, reflecting investments in infrastructure and market expansion [6]. Loan and Deposit Growth - The loan pipeline increased by 35% Y/Y, with approximately $50 million in approved loans expected to fund in 1Q26. Loan growth was reported at 7% compared to September 30, 2025 [3]. - Total loans grew by 13% Y/Y and 7% quarter-over-quarter (LQ) in 4Q25, with significant contributions from commercial real estate (CRE), commercial and industrial (C&I), and residential loans [4]. - Deposits increased by 19% Y/Y, driven by a 50% growth in interest-bearing transaction balances and an 11% increase in noninterest-bearing deposits [5]. Asset Quality and Capital - Asset quality remains healthy, with net charge-offs (NCOs) at 2.26% of average loans in 4Q25, primarily related to the fraudulent loan. Nonperforming loans (NPLs) decreased to 0.60% of loans at year-end [13]. - The company maintained a strong capital position, with a tier-1 leverage ratio of 10.66% and a common equity tier-1 capital ratio of 10.97% as of 4Q25 [14]. Strategic Developments - InsCorp's board welcomed Nancy Schultz, a healthcare industry veteran, to enhance its expertise in healthcare services [15]. - The company has authorized a new share repurchase plan for 100,000 shares, representing 3.4% of its outstanding shares [15].